Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
about
Comparison of hepatocellular carcinoma in Eastern versus Western populations.The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular CarcinomaRisk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response.Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study.Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countriesPhase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment.The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinomaA novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosisRamucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.Ongoing challenges in the diagnosis of hepatocellular carcinoma.Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.Global trends in the burden of liver cancer.Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells.Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy.The evolutionary scenario of hepatocellular carcinoma in Italy: an update.Spontaneous Rupture of Renal Metastasis from Hepatocellular CarcinomaMolecular Targeted Therapy for Hepatocellular Carcinoma: Where Are We Now?Enhanced recovery program versus traditional care after hepatectomy: A meta-analysisRegorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma.Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B.Fruiting Bodies of Antrodia cinnamomea and Its Active Triterpenoid, Antcin K, Ameliorates N-Nitrosodiethylamine-Induced Hepatic Inflammation, Fibrosis and Carcinogenesis in Rats.Can Kushen injection combined with TACE improve therapeutic efficacy and safety in patients with advanced HCC? a systematic review and network meta-analysis.Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case-control study with propensity score matching.Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm.Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation.The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization.Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.Imaging performance and clinical value of contrast-enhanced ultrasonography and computed tomography in the diagnosis of liver cancer.Knowledge-based IMRT planning for individual liver cancer patients using a novel specific model.Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still outIdentification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
P2860
Q30245396-3FCB005A-1248-412E-8B8C-7A6A0B72B579Q30250096-4966B0C7-4056-4107-A407-9DF9E8536155Q30388235-45B92D3E-665D-42D7-8E07-D56FE985C1DFQ37124717-16060421-8CC3-4845-AC6B-2BB23C164452Q37284654-F00183EC-2D47-40D7-BC43-19EE4E71A985Q37399648-0F591B46-AE9B-4763-B3F0-B36649BEDDA4Q37544401-09C376D3-1227-4EF9-B837-954FDD63C894Q37648559-4A50AE2F-52CE-4042-8EA3-C7DABC66E46FQ37702806-EA31B50E-0B5C-4C15-831C-5B040A609186Q38388551-D33FACBB-A7A5-4370-BA23-3C86D5540F77Q38635603-B5193738-D567-4AD8-9BA3-2E7091A3B21CQ38646886-462FB14D-DDF9-47E9-8A91-F3DC0F06E1F9Q38717563-97C9B5BB-2A9E-4FC9-8DC5-09618002A6B7Q38739412-D1374205-EF0C-41B6-8E8C-2CB9A7FCD92AQ38772085-4DA5A9E0-0491-4F89-9418-5693992C4143Q40597524-0C4A06A6-4884-4E9E-AF2F-8EA2B84DDA9DQ40646684-CC8491E7-6A5C-4E87-8636-4281BC3BA6DCQ42000676-6D071439-E88A-4E11-936E-63E1B5F14BD3Q42169289-C61A8562-0DD4-446A-B80E-878603610A87Q42365428-ED117388-E547-4D3A-AD05-0E082714A334Q42380812-BCC88E37-F90B-4528-9511-28105DD303C4Q42723781-3DA72F00-F775-4F2B-B180-1A533DD7297AQ46433389-9D368ADE-0BE8-4EC8-AA80-A8676EA34C9DQ47135992-1E67F2A9-CCBC-4CBB-A3EE-551550EC916CQ47147535-F90915BD-0985-4EA8-964D-DAAD025A472EQ47332345-4F060B55-A1AE-4F9D-ACF5-B03338F46B9AQ47621525-CB12BF7E-6682-4FA3-8547-E72DE5E1D9D8Q47796915-D61F02CD-08CC-4792-A7E5-5DF2975E43C4Q49884601-AE8FDB74-A6AD-4910-9A23-BF1B5F3029A5Q50579308-7F373740-9397-4E58-9419-4E19D7779795Q52817072-C4370A42-4146-48B7-A598-03C6D0C00DBAQ53212995-F21CF3E7-1013-4B08-9F3E-03AF4F8FAAD9Q54945895-B1164762-DC7C-4A87-9D18-50409699851DQ54973526-E3519ED7-0CE6-46EC-9227-911EC4331E69Q54978814-39C10669-EE07-4387-94B5-6227DDEB0C4BQ55349731-2F8A80C6-A3F6-4FEE-8E4A-DF46742E05B0Q57781146-47CC5CAF-0B7E-4785-9851-43993BF5A407Q58782758-97AF51AB-61CB-48C7-824B-AFB41B1B595E
P2860
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@ast
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@en
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@nl
type
label
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@ast
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@en
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@nl
prefLabel
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@ast
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@en
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@nl
P2860
P3181
P356
P1433
P1476
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan
@en
P2093
Masatoshi Kudo
P2860
P3181
P356
10.1159/000367727
P407
P577
2015-03-01T00:00:00Z